NTLA · Forms 3, 4, 5
Insider trades at Intellia Therapeutics, Inc.
1 insider sold $23K of Intellia Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Intellia Therapeutics, Inc. (NTLA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Michael P Dube | VP, Chief Accounting Officer | Sell | 1,864 | $12.43 | $23K | Form 4 | |
| John M Leonard | President and CEO | Sell (10b5-1 plan) | 2,785 | $13.00 | $36K | Form 4 | |
| John M Leonard | President and CEO | Sell (10b5-1 plan) | 19,890 | $12.60 | $251K | Form 4 | |
| Edward J Dulac III | EVP, Chief Financial Officer | Sell | 8,111 | $11.25 | $91K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.